recommended by 

Notfalllabor

 

 

INNOVATION FOR LIFE

The early detection of emergencies such as heart attack and stroke is one of the key factors and it has a decisive influence on the life-or-death of the affected people. With the development of our innovative diagnostic products, it is our goal to find better and more effective solutions for the early identification of such essential health disorders.

 

SEGMENTS AND PATIENT NUMBERS

 

 

Gynkologie Bearbeitet2

10.000.000
PRE-ECLAMPSIA PATIENTS

DATA:
5-8 % PREGNANCIES ARE ACCOMPANIED BY PRE-ECLAMPSIA
(7 TIMES HIGHER IN THIRD WORLD COUNTRIES)
12.5 / 1,000 PREGNANCIES

WORLDWIDE 135 MIO. BIRTHS

 

 

 

Neurologie Bearbeitet2
 
  

15.000.000
STROKE PATIENTS

RISK FACTORS:
HIGH BLOOD PRESSURE
UNHEALTHY LIFESTYLE
OBESITY
GENETIC PREDISPOSITION  

 

 

 

Kardiologie Bearbeitet2
 

77.000.000
ACS / CHEST PAIN PATIENTS

RISK FACTORS:
HIGH BLOOD PRESSURE
UNHEALTHY LIFESTYLE
OBESITY (AROUND 27%)
GENETIC PREDISPOSITION

 

 

 


 

 

PRODUCT OVERVIEW

 

 

01653__j2

GYNECOLOGY

There is no established bio marker for preeclampsia yet.

This sets GPBB as the new gold standard for the diagnosis of preeclampsia.


NEUROLOGY

There are no bio markers to detect a stroke yet.

This sets GPBB as the new gold standard for stroke detection.

This leads to the input and improvements of stroke diagnosis guidelines.


CARDIOLOGY

GPBB is able to recognize AMI / ACS early after onset of chest pain [30min]. It is therefore faster than today's bio markers [4h]. This will establish GPBB as the new gold standard for the early diagnosis of ACS.